Early-stage ortho companies obsess over what’s in their grasp—patents, funding, slick prototypes, quality systems, and the FDA/EU regulatory circus. This is only natural.
They’re polishing their toys while the real game’s being rigged elsewhere. The orthopedic device world isn’t about who builds the best implant; it’s a gauntlet of systemic traps ready to choke your startup before it breathes. Here’s the contrarian truth: three hidden assassins—reimbursement chaos, sales force flops, and hospital overlords—are laughing at your R&D budget.
1/ Reimbursement Roulette
Forget patient demand—i...
